TAIPEI, June 4, 2026 /PRNewswire/ -- SynaXG, Aethertek, and Metanoia today announced the industry's powered end-to-end AI-RAN-enabled FR2 5G network solution, integrating SynaXG's AI-RAN Central Unit (CU) and Distributed Unit (DU)...

TAIPEI, June 4, 2026 /PRNewswire/ -- LITEON Technology announced a major milestone in AI-RAN innovation through its collaboration with the Singapore University of Technology and Design (SUTD) and SUTD's spinoff...

TAIPEI, June 4, 2026 /PRNewswire/ -- LITEON Technology announced a major milestone in AI-RAN innovation through its collaboration with the Singapore University of Technology and Design (SUTD) and SUTD's spinoff...

Traveloka's 6.6 Mid-Year Sale: Flights, Hotels and Activities from RM66KUALA LUMPUR, Malaysia, June 4, 2026 /PRNewswire/ -- Traveloka, Southeast Asia's all-in-one travel tech platform, today announced its 6.6 Mid-Year Sale...

Traveloka's 6.6 Mid-Year Sale: Flights, Hotels and Activities from RM66 KUALA LUMPUR, Malaysia, June 4, 2026 /PRNewswire/ -- Traveloka, Southeast Asia's all-in-one travel tech platform, today announced its 6.6 Mid-Year...

TAIPEI, June 4, 2026 /PRNewswire/ -- HKC, ANTGAMER and KOORUI made a joint appearance at COMPUTEX 2026 under the theme "Win Beyond the Frame," showcasing a new lineup of display...

TAIPEI, June 4, 2026 /PRNewswire/ -- HKC, ANTGAMER and KOORUI made a joint appearance at COMPUTEX 2026 under the theme "Win Beyond the Frame," showcasing a new lineup of display...

Collaboration combines SKAI Intelligence's industrial synthetic-data pipeline with Korea's leading AI research institution Joint research to advance robotic perception, grasping, and vision technologies for real-world Physical AI applications Partnership aims...

Collaboration combines SKAI Intelligence's industrial synthetic-data pipeline with Korea's leading AI research institution Joint research to advance robotic perception, grasping, and vision technologies for real-world Physical AI applications Partnership aims...

SEOUL, South Korea, June 4, 2026 /PRNewswire/ -- MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to conduct a...